ScripFrontline Indian firms appear keen to accelerate product in-licensing deals with foreign companies and these efforts have now evolved from a “supplementary tactic” to a cornerstone of their strategy,
ScripNovo Nordisk’s Wegovy (injectable semaglutide) has made its India debut, setting the stage for a tight battle with rival Eli Lilly’s Mounjaro (tirzepatide) in a market where an estimated 254 million p
Generics BulletinDr Reddy’s and Alvotech have struck a further biosimilars alliance, announcing today a co-development partnership for a rival to Merck & Co/Merck Sharp & Dohme’s top-selling Keytruda (pembroli
ScripA high-profile expert panel that included renowned clinician-scientist and director of the Cancer Science Institute of Singapore, Prof Ashok Venkitaraman, discussed some of the pressing global public